A new, visionary Corporate Plan, setting out how the Medicines and Healthcare products Regulatory Agency plans to keep patients safe by enabling access to innovative, safe and effective medical products over the coming three years, has been published today (4 July 2023).
Years into an addiction crisis, a med school lecture still minimized opioid risks
Amid ongoing concern over opioid addiction, a university in Florida has been criticized for allowing a lecture that conveyed “false and misleading” information about the